Institutional investors purchased a net $2.7 million shares of OPK during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 17.76% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SMITH ASSET MANAGEMENT GROUP LP Bought 95.9 Thousand shares of OPKO Health Inc
HHG & CO LLC Bought 36.8 Thousand shares of OPKO Health Inc
HOLLENCREST SECURITIES LLC Bought 30.0 Thousand shares of OPKO Health Inc